Carbon Disulfide

A colorless, flammable, poisonous liquid, CS2. It is used as a solvent, and is a counterirritant and has local anesthetic properties but is not used as such. It is highly toxic with pronounced CNS, hematologic, and dermatologic effects.

Also Known As:

Networked: 334 relevant articles (2 outcomes, 28 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Shih, Tung-Sheng: 8 articles (08/2011 - 05/2002)
2.	Huang, Chin-Chang: 6 articles (08/2011 - 05/2002)
3.	Chang, Ho-Yuan: 4 articles (11/2004 - 01/2003)
4.	Song, Fuyong: 3 articles (09/2014 - 06/2009)
5.	Xie, Keqin: 3 articles (09/2014 - 06/2009)
6.	Jhun, Hyung-Joon: 3 articles (07/2009 - 03/2003)
7.	Chou, Tzu-Chieh: 3 articles (01/2007 - 10/2003)
8.	Hammel, Jeffrey P: 2 articles (07/2015 - 12/2014)
9.	Lourdusamy, Dennisdhilak: 2 articles (07/2015 - 12/2014)
10.	Parsi, Mansour A: 2 articles (07/2015 - 12/2014)

Related Diseases

1.	Poisoning 06/01/2012 - "The subjects of present study were 267 patients with mild CS(2) poisoning diagnosed according to "Diagnostic Criteria of Occupational Chronic Carbon Disulfide Poisoning (GBZ4-2002)" from April in 2006 to May in 2010. " 07/01/2002 - "Ninety-one patients who had suffered carbon disulfide poisoning [male:female=87:4; age, 32-74 (mean 53.3) years] were included in this study. " 01/01/1996 - "A mortality study of workers with reported chronic occupational carbon disulfide poisoning." 01/01/1979 - "[Studies on clinical usefulness of audiometry and electronystagmography in the diagnosis of chronic carbon disulfide poisoning]." 09/06/1976 - "Studies on chronic carbon disulfide poisoning. "
2.	Nervous System Diseases (Neurological Disorders) 07/01/1953 - "[Neurologic disorders caused by carbon disulfide: symptomatology, pathologic anatomy, relations to other neuropathies, diagnosis]." 12/01/2010 - "Outbreaks of occupational neurological disorder of the CNS due to inorganic mercury and carbon disulfide poisoning had helped prompt the development of the occupational safety and health system of Korea. "
3.	Infection 03/01/1975 - "Controlled tests of the efficacy of bot-active compounds, dichlorvos, trichlorfon, trichlorfon butonate, and carbon disulfide on the larvae of Gasterophilus intestinalis and Gasterophilus nasalis during their migratory period in the tissue of the mouth of horses and ponies were completed on experimentally induced and naturally acquired infections. "
4.	Coronary Disease (Coronary Heart Disease) 01/01/2001 - "The objectives of this study were to investigate the cardiovascular effects in workers currently exposed to carbon disulfide (CS2) below the threshold limit value (TLV) of 31 mg/m3 and to determine the prevalence of coronary heart disease (CHD) after long-term exposure. " 09/01/1974 - "[Study of the incidence of coronary disease in pensioned workers of a viscose-rayon factory exposed to carbon disulfide]." 08/01/2011 - "Overexposure to carbon disulfide (CS(2) ) has been associated with an increase in coronary heart disease, but the mechanisms mediating this effect remain unclear. " 09/01/2007 - "Evidence for oxidative stress at elevated plasma thiol levels in chronic exposure to carbon disulfide (CS2) and coronary heart disease." 01/01/1984 - "[Results of a longitudinal study of coronary diseases in occupational exposure to carbon disulfide]."
5.	Parkinsonian Disorders (Parkinsonism) 01/01/1957 - "[Toxic parkinsonism with Quarelli syndrome & cardiovascular disorders after chronic carbon disulfide poisoning]." 04/22/1950 - "[New case of Parkinsonism due probably to carbon disulfide poisoning]." 03/01/2004 - "Dopamine transporter binding study in differentiating carbon disulfide induced parkinsonism from idiopathic parkinsonism." 01/01/2003 - "Long-term exposure to carbon disulfide (CS(2)) may induce diffuse encephalopathy with parkinsonism, pyramidal signs, cerebellar ataxia, and cognitive impairments, as well as axonal polyneuropathy. " 04/01/1977 - "If this is so, then some other toxic effects of carbon disulfide, including parkinsonism, choreoathetosis, and thalamic syndrome may follow the ingestion of more than 5 g of disulfiram by adults, and individuals receiving as little as 125 mg of disulfiram per day may be at a three- to four-fold greater risk for arteriosclerotic cardiovascular disease than a comparable population not receiving the drug."

Related Drugs and Biologics

1.	Trichlorfon (Metrifonate)
2.	Mercury
3.	Dichlorvos
4.	butonate
5.	Cholesterol
6.	Benzene (Benzole)
7.	Styrene (Styrol)
8.	Toluene
9.	Asbestos
10.	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)

Related Therapies and Procedures

1.	Lasers (Laser)
2.	Oral Administration